z-logo
open-access-imgOpen Access
Anti-cardiolipin antibodies in sexual partners of recurrent aborters
Author(s) -
James A. Panton,
D. C. Kilpatrick
Publication year - 1997
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/12.3.464
Subject(s) - recurrent miscarriage , miscarriage , medicine , gynecology , cardiolipin , population , obstetrics , abortion , pregnancy , biology , phospholipid , genetics , environmental health , membrane
The presence of anti-cardiolipin antibodies (aCL) in women is an established risk factor for fetal loss, but these autoantibodies had not previously been investigated in the male partners of recurrent aborters. The prevalence of aCL in 144 male partners of couples with a history of recurrent miscarriage was 4.2%, which compares with 2.8% for 177 female partners of such couples, 5.9% of 254 blood donors (128 male, 126 female) and 0% of 74 women of good obstetric history sampled in the puerperium. In recurrent miscarriage couples, the presence of aCL in the women was associated with a poorer history and outlook, but these associations were not evident in couples where the male partner had aCL. The aCL of male partners also differed from those of their spouses in being less likely to show higher activity towards phosphatidylserine than towards phosphatidylcholine. A particular sub-population of aCL may be strongly represented in the male partners, the clinical significance of which remains to be established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom